CIC
RMD icon

Crawford Investment Counsel’s ResMed RMD Stock Holding History

Crawford Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
1,081
-170
-14% -$35.2K ﹤0.01% 300
2026
Q1 		$281K Sell
1,251
-857
-41% -$214K ﹤0.01% 276
2025
Q4 		$508K Sell
2,108
-202
-9% -$51.7K 0.01% 253
2025
Q3 		$632K Sell
2,310
-940
-29% -$257K 0.01% 236
2025
Q2 		$839K Sell
3,250
-4,384
-57% -$1.05M 0.01% 216
2025
Q1 		$1.71M Buy
7,634
+461
+6% +$108K 0.03% 189
2024
Q4 		$1.64M Buy
7,173
+1,051
+17% +$253K 0.03% 191
2024
Q3 		$1.49M Buy
6,122
+80
+1% +$17.9K 0.03% 192
2024
Q2 		$1.16M Buy
6,042
+2
+0% +$406 0.02% 189
2024
Q1 		$1.2M Buy
6,040
+524
+9% +$96K 0.02% 183
2023
Q4 		$949K Buy
+5,516
New +$847K 0.02% 191
2023
Q3 		– Sell
-1,001
Closed -$219K – 275
2023
Q2 		$219K Hold
1,001
– – ﹤0.01% 269
2023
Q1 		$219K Sell
1,001
-11
-1% -$2.39K ﹤0.01% 266
2022
Q4 		$211K Hold
1,012
– – ﹤0.01% 269
2022
Q3 		$221K Sell
1,012
-45
-4% -$10.2K 0.01% 263
2022
Q2 		$222K Sell
1,057
-121
-10% -$25.8K ﹤0.01% 268
2022
Q1 		$286K Hold
1,178
– – 0.01% 262
2021
Q4 		$307K Sell
1,178
-19
-2% -$4.93K 0.01% 256
2021
Q3 		$315K Buy
1,197
+6
+0.5% +$1.64K 0.01% 260
2021
Q2 		$294K Buy
1,191
+19
+2% +$3.99K 0.01% 260
2021
Q1 		$227K Buy
1,172
+11
+0.9% +$2.21K 0.01% 271
2020
Q4 		$247K Buy
+1,161
New +$231K 0.01% 256
2020
Q3 		– Sell
-1,161
Closed -$223K – 272
2020
Q2 		$223K Buy
+1,161
New +$190K 0.01% 252

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Crawford Investment Counsel's RMD Position: Q2 2026 in Review

Crawford Investment Counsel reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $35.2K and leaving 1,081 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Crawford Investment Counsel first reported a position in RMD in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.71M in Q1 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Crawford Investment Counsel held 1,081 shares of ResMed worth $211K as of Q2 2026.
  • Crawford Investment Counsel sold 170 ResMed shares in Q2 2026, an estimated $35.2K.
  • ResMed made up ﹤0.01% of Crawford Investment Counsel's portfolio in Q2 2026, its #300 holding.
  • Crawford Investment Counsel first reported a position in ResMed in Q2 2020 and has held it in 23 quarters since.
  • Crawford Investment Counsel's ResMed position peaked at $1.71M in Q1 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.